Breast cancer
Conditions
Interventions
Total:All patients were treated according to NCCN guidelines, 7.5ml peripheral venous blood to take suction
Sponsors
Southwest Hospital, Third Military Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. The patients agree to participate in the trials and sign the informed consent and date; 2. Aged 18-70 years; 3. Be able to follow the scheme; 4. No other malignancy; 5. Patients were diagnosed with breast cancer; 6. ECOG score must be 0 or 1; 7. Enough blood functions: 1) absolute neutrophil count (ANC >=1.5*10^9/L) and 2) platelet count >=100*10^9/L and 3) hemoglobin >=9g/dL (May through blood transfusions to maintain or exceed This levels); 8. Adequate liver function: total bilirubin =50 mL/min, and urine protein <2 +; 10. Clotting function: the first 7 days into the group of international normalized ratio (INR) <=1.5, and partial thromboplastin time (PPT or aPTT) <=1.5 ULN.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating female patients; 2. Tumor resection finished; 3. Still in other study at the same time; 4. Patients with clear surgical contraindications; 5. The researchers believe that the patients are not suitable for this clinical trial for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic accuracy;Specificity;Sensitivity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival;Response rate;Overall Survival; | — |
Countries
China
Contacts
Public ContactJun Jiang
Outcome results
None listed